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South Africa (SA) remains in a national state of disaster due to 
COVID-19 and the ongoing detection of active SARS-CoV-2 cases in 
our population, mainly driven by  the local Beta variant 501Y.V2. Our 
nation’s recorded recovery rate remains high at 92%.[1] Groote Schuur 
Hospital (GSH), one of the two state academic hospitals in our area, 
services patients from vulnerable communities, where infectious 
diseases such as tuberculosis and HIV continue to dominate the 
health landscape and multiple comorbidities exist, posing a potential 
risk for the development of more severe forms of COVID-19-
associated illness. Many of our orthopaedic patients are from a low 
socioeconomic background and low-income households, associated 
with potential vulnerabilities.
At GSH, both elective and non-urgent surgeries were cancelled 
during the initial phases of the hard lockdown, 26 March to the 
end of May 2020.[2] After the initial hard lockdown, we resumed 
semi-urgent surgeries in lower-risk patients. We used the medically 
necessary, time-sensitive procedures (MeNTS) scoring system to help 
select the most appropriate orthopaedic patients to perform surgery 
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Background.  Initial local and global evidence suggests that SARS-CoV-2-infected patients who undergo surgery, and those who become 
infected perioperatively, have an increased mortality risk post surgery.
Objectives. To analyse and describe the 30-day mortality, presurgical COVID-19 status and hospital-acquired SARS-CoV-2 infection rates of 
patients, both SARS-CoV-2-positive and negative, undergoing orthopaedic surgery at a tertiary academic hospital in South Africa (SA) during 
the first COVID-19 peak.
Methods. This single-centre, observational, prospective study included patients who underwent orthopaedic procedures from 1 April 2020 
(beginning of the COVID-19 case increase in SA) to 31 July 2020 (first COVID-19 peak in SA). All patients were screened for COVID-
19 and were confirmed positive if they had a positive laboratory quantitative polymerase chain reaction test for SARS-CoV-2 RNA on a 
nasopharyngeal or oral swab. Thirty-day mortality, presurgical COVID-19 status and hospital-acquired SARS-CoV-2 infection were assessed.
Results.  Overall, a total of 433 operations were performed on 346 patients during the timeframe. Of these patients, 65.9% (n=228) were 
male and 34.1% (n=118) were female. The mean (standard deviation) age was 42.5 (16.8) years (range 9 - 89). Of the patients, 5 (1.4%) were 
identified as COVID-19 patients under investigation (PUI) on admission and tested positive for SARS-CoV-2 before surgery, and 1 (0.3%) 
contracted SARS-CoV-2 perioperatively; all survived 30 days post surgery. Twenty-nine patients were lost to follow-up, and data were missing 
for 6 patients. The final analysis was performed excluding these 35 patients. Of the 311 patients included in the final 30-day mortality analysis, 
303 (97%) had a follow-up observation ≥30 days after the operation. The overall 30-day mortality for these patients was 2.5% (n=8 deaths). 
None of the recorded deaths were of screened COVID-19 PUI.
Conclusions. We report a low 30-day mortality rate of 2.5% (n=8) for patients undergoing orthopaedic surgery at our hospital during the 
first COVID-19 peak. None of the deaths were COVID-19 related, and all patients who tested SARS-CoV-2-positive, before or after surgery, 
survived. Our overall 30-day mortality rate correlates with several other reports of orthopaedic centres analysing over similar timeframes during 
the first peak of the COVID-19 pandemic. Regarding mortality and SARS-CoV-2 infection risk, we can conclude that with the appropriate 
measures taken, it was safe to undergo orthopaedic procedures at our hospital during the first peak of the COVID-19 pandemic in SA.
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on.[3] At the time of writing, elective and 
non-urgent surgeries were actively resuming 
and patients were once again returning to 
hospitals to seek diagnosis and treatment. It 
remains a top priority to continue ensuring 
that both patients and healthcare workers 
are protected from contracting SARS-
CoV-2 in the course of patient treatment. 
A primary focus should be how to safely 
and fully reinstate elective and non-urgent 
operating amid the current pandemic and 
the devastating ‘waves’. Here, it is of key 
importance to provide evidence regarding 
the safety of surgery in hospitals with high 
SARS-CoV-2 risk. It is also valuable to 
assess how COVID-19 may affect surgical 
outcomes of patients treated during this 
time, as initial global evidence has suggested 
that COVID-19-positive patients who 
undergo surgery have significantly increased 
mortality and risk of major complications 
post surgery.[4-9] There is limited evidence of 
the impact of COVID-19 on the mortality of 
orthopaedic patients undergoing surgery in 
resource-limited settings.
Objectives
To assess the pre- and perioperative COVID-
19 status and 30-day mortality of all patients 
who underwent orthopaedic surgery during 
the first peak of the COVID-19 pandemic 
in our tertiary academic hospital. To our 
knowledge, no reports on the 30-day 
mortality of orthopaedic patients in a 
level 1 orthopaedic trauma unit in an SA 
environment are available.
Methods
Study design and data source
After obtaining ethical (ref. no. HREC 250/ 
2020) and hospital institutional approval, 
orthopaedic surgical case data for the 
timeline 1 April 2020 - 31 July 2020 were 
extracted from a prospectively collected 
orthopaedic REDCap database, while 
maintaining patient confidentiality. All 
patients presenting to the orthopaedic 
department were screened for COVID-19 
using standardised screening questions and 
identified as patients under investigation 
(PUI) if they exhibited COVID-19-related 
signs and symptoms including a history 
of fever, shortness of breath, cough, sore 
throat and/or loss of smell and taste, and/or 
if they had recently travelled abroad or had 
contact with an individual with suspected or 
confirmed SARS-CoV-2. Only the COVID-
19 PUI underwent a nasopharyngeal or oral 
swab for detection of SARS-CoV-2 RNA 
by quantitative polymerase chain reaction 
(PCR), as per hospital guidelines.
We attempted to contact by telephone all 
identified orthopaedic patients (n=346) 
who under went surgery during the study 
period. Patients who were successfully 
contacted provided telephonic consent for 
the investigators to assess their COVID-19 
status and the status of their household 
members, and if applicable, information 
on patient mortality. In addition, all 
identified patients were screened using the 
Picture Archiving and Communication 
System  (PACS) imaging database to assess 
the date of latest imaging results for the 
purpose of understanding patient 30-day 
mortality. Concurrently, all 346 patients 
were also screened using the National Health 
Laboratory Service (NHLS)-LABTRAK 
(TrakCare) system, both for latest result 
dates to assess 30-day mortality, for those 
unsuccessful on the PACS system, and for 
SARS-CoV-2 PCR results. Patient folders 
were extracted and Clinicom was accessed 
for patients who had neither a PACS nor 
an NHLS follow-up date post surgery, to 
assess last-seen dates and 30-day mortality, 
if known to be deceased.
Statistical analysis
Patient demographic data were summarised 
using descriptive statistics, including means 
and ranges, where applicable.
Results
A total of 433 orthopaedic surgical proce dures 
were performed on 346 patients from 1 April 
to 31 July 2020. All 346 patients were screened 
for COVID-19 signs and symptoms on 
admission. Of these, 36 (10.4%) were identified 
as PUI and underwent a nasopharyngeal 
swab for diagnostic testing by the NHLS 
using a SARS-CoV-2 PCR; 5 (13.9%) were 
confirmed SARS-CoV-2-positive, 28 (77.8%) 
were confirmed SARS-CoV-2-negative, and 
3 (8.3%) had inconclusive results or tests 
rejected due to incorrect sample labelling 
(Fig. 1 and Table 1). Two hundred and eighty-
one orthopaedic patients were not swabbed 
for SARS-CoV-2 because they screened 
negative for COVID-19 high risk according 
to the hospital swabbing guidelines at the 
time. Assessment of presurgical COVID-19 
status for 29 patients was unsuccessful owing 
to incorrect recording of folder numbers on 
the REDCap database or lack of 2020 data on 
the TrakCare system (Fig. 1).
Of the patient cohort, 65.9% (n=228) were 
male. The mean (standard deviation) age 
of the entire patient cohort was 42.5 (16.8) 
years (range 9 - 89) (Table 1). The ages of 
2 patients were unrecorded or unavailable 
owing to incorrect folder numbers recorded 
on the REDCap database.
Of the patients, 56.9% underwent surgery 
for orthopaedic trauma. There was an equal 
spread among the rest of the orthopaedic 
surgical firms, with the exception of spine 
trauma (2.3%), foot and ankle (1.4%) and 
paediatric non-trauma (0.3%) (Table 1).
Available data for our orthopaedic surgical 
cohort for the 30-day mortality assessment 
are shown in Fig. 2. A total of 35 patients were 
excluded from the final analysis (dotted line-
framed boxes) because the patient hospital 
folder number was incorrectly recorded on 
the orthopaedic REDCap database (n=6) or 
the patients were lost to follow-up (LTFU) 
post surgery (n=29). Of the remaining 311 
patients, 303 (97.4%) had a ≥30-day follow-
up date (PACS, NHLS, telephonic follow-
up, folder retrieval), of whom 177 (58.4%) 
were successfully contacted telephonically. 
The overall 30-day mortality for our patient 
Patients undergoing orthopaedic 
surgical procedures and screened 
for COVID-19 signs and symptoms,
N=346
COVID-19-positive screen, 
identied as PUI and swabbed 
for SARS-CoV-2 PCR, n=36
COVID-19-negative screen,
n=281
No match/incorrect data 








Fig. 1. Flow chart showing screening of our orthopaedic surgical cohort for COVID-19 signs and 
symptoms on admission. (PUI = patients under investigation; PCR = polymerase chain reaction; 
NHLS = National Health Laboratory Service.)
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cohort was 2.5% (n=8 deaths). Of the 8 patients who died during 
the study period, 87.5% (n=7) underwent trauma-related surgery 
and 1 patient underwent a cervical spine fusion. There was an equal 
ratio between males and females who died postoperatively. None 
of the recorded deaths were of COVID-19 PUI on admission. Of 
the patients confirmed positive for SARS-CoV-2 who underwent 
surgery during the timeframe, 80.0% were male. The most common 
procedure performed was open reduction and internal fixation of a 
fracture. One orthopaedic trauma patient (0.3%) contracted SARS-
CoV-2 perioperatively (Table 1). After 30 days, 100% survival was 
recorded for all patients who were admitted with SARS-CoV-2 or 
contracted it during the postoperative period.
Discussion
To our knowledge, this is the first SA study to have analysed and 
described the 30-day mortality and pre- and perioperative SARS-
CoV-2 infection status of orthopaedic patients undergoing surgery at 
a tertiary academic hospital during the first wave of the COVID-19 
pandemic.
As we actively resume elective and non-urgent surgical procedures 
between waves of the COVID-19 pandemic, it is important to 
acknowledge the continued SARS-CoV-2-exposure risks, both to 
patients and to surgical staff. Most of the patients in our study cohort 
underwent surgery for trauma-related injuries, which inherently 
carries an increased risk to the patient. The risks due to SARS-
Table 1. Cohort demographics, surgery details, 30-day mortality and pre- and perioperative SARS-CoV-2 infection details for 
orthopaedic patients operated on during the first wave of the COVID-19 pandemic in South Africa, 1 April 2020 - 31 July 2020
Variable Overall Non-trauma* Trauma
Gender, n (%)
Total 346 (100) 149 (43.1) 197 (56.9)
Male 228 (65.9) 89 (39.0) 139 (61.0)
Female 118 (34.1) 60 (50.8) 58 (49.2)
Age (years), mean (SD, range) 42.5 (16.8, 9 - 89) 44.02 (17.61, 9 - 89) 41.26 (16.1, 14 - 88)†
Surgical procedures per surgical firm, %
Arthroplasty 9.0 - -
Foot/ankle 1.4 - -
Knee 6.6 - -
Limb reconstruction unit 7.5 - -
Oncology 5.2 - -
Paediatric non-trauma 0.3 - -
Spine 6.6 - -
Spine trauma 2.3
Trauma 56.9 - -
Upper limb 4.0 - -
30-day mortality characteristics
Total, n (% of total patient cohort) 8 (2.5) 1 (12.5) 7 (87.5)
COVID-19 PUI on admission, n 0 0 0
Age (years), mean (SD, range) 57.5 (18.02, 30 - 83) - 59.14 (18.8, 30 - 83)
Procedures, n (% of total patient cohort) 8 (2.5) 1 (12.5) 7 (87.5)
ORIF (nail), n 2 - 2
ORIF (plate), n 1 - 1
MUA, n 1 - 1
Cervical spine fusion, n 1 1 -
Soft-tissue debridement, n 1 - 1
Removal of hardware, n 1 - 1
Soft-tissue shoulder arthrotomy, n 1 - 1
Pre- and perioperative SARS-CoV-2-positive patient characteristics and surgery detail
 Preoperative SARS-COV-2 confirmed infection,  
n (% of total patient cohort)
5 (1.4) - 5 (100)
Age (years), mean (SD, range) 42.2 (15.97, 21 - 65) - 42.2 (15.97, 21 - 65)
Procedures, n (% of total patient cohort) 5 (1.4) - 5 (100)
ORIF (nail), n 2 - 2
ORIF (plate), n 1 - 1
Amputation, n 1 - 1
Cemented bipolar, n 1 - 1
 Perioperative SARS-COV-2 confirmed infection,  
n (% of total patient cohort)
1 (0.3) - 1 (100)
Procedure – ORIF (plate), n (% of total patient cohort) 1 (0.3) - 1 (100)
SD = standard deviation; PUI = patients under investigation; ORIF = open reduction internal fixation; MUA = manipulation under anaesthesia.
*Non-trauma includes the following surgical firms: arthroplasty, foot and ankle, knee, limb reconstruction unit, oncology, paediatric non-trauma, spine, spine trauma, and upper limb.
†2 patients omitted owing to lack of birthdate data.
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CoV-2 infection, in SARS-CoV-2 confirmed 
positive patients on admission, may 
compound this general risk, and outcomes 
could be unfavourable for the patient. 
Despite these risks, all our SARS-CoV-2 
confirmed positive patients undergoing 
surgery survived 30 days post surgery. Of 
our cases, 43.1% were non-trauma, as we 
were actively conducting urgent and semi-
urgent orthopaedic procedures during this 
time.
Globally, several orthopaedic units have 
assessed the 30-day mortality and SARS-
CoV-2 infection rates of patients undergoing 
procedures during their respective first 
peaks of the COVID-19 pandemic. Most 
of the study sites, including in the UK, 
Europe and the USA, experienced their first 
COVID-19 peak in March and April 2020, 
earlier than that experienced in SA in July 
2020. We have summarised and described 
the findings in Table 2. The low 30-day 
mortality rate of our patient cohort during 
the first COVID-19 peak is similar to figures 
published by Sobti et al.,[10] Karayiannis 
et al.,[11] Price et al.,[12] Hope et al.[13] and 
Giorgi et al.[14] (2.3% v. 4.3%, 1.9%, 3%, 4% 
and 4.6%, respectively), and is considerably 
lower than mortality rates reported in other 
regions in the UK and other developing 
countries (11.76% - 53%).[5,7-9,13] The specific 
reasons for this lower mortality rate are not 
clear from our study, but may be attributed 
to an overall younger population undergoing 
surgery in our academic hospital and many 
lower-risk procedures being performed 
during this timeframe. We show that surgery 
was, for the most part, safely conducted 
despite the risk of SARS-CoV-2 infection 
and postoperative complications. Various 
factors must be taken into account when 
allocating theatre resources for elective and 
non-urgent surgery during the pandemic. 
The availability of nursing and surgical staff, 
limited ward space and decreased oxygen 
supply, as well as health-seeking behaviour 
of patients, have influenced surgical 
processes during the COVID-19 peaks. 
Yet, owing to the low risk of postoperative 
complications in our cohort, a fear of higher 
mortality in well-selected elective surgery 
was not justified. This specific concern 
should therefore receive lower priority when 
considering theatre resource allocation in 
future waves of the pandemic.
As previously mentioned, our lower 
30-day mortality rate was similar to 
several international studies, including 
the experience of a UK trauma and 
orthopaedics unit where 206 trauma and 
urgent orthopaedic surgical procedures were 
performed during the peak of the pandemic 
(1 March - 31 May 2020).[10] Of these 
patients, 4.3% (n=9) died postoperatively; 
55.5% of the deceased patients were 
SARS-CoV-2-negative, 1.45% (n=3) were 
SARS-CoV-2-positive postoperatively, and 
1 patient presented as asymptomatic and 
was not tested before surgery. The authors 
promote the usefulness of comparing and 
evaluating single-centre practice. A study 
that collated Northern Ireland regional 
data showed very low (1.9%) overall 
30-day postoperative mortality in trauma 
and orthopaedic surgery patients. Of the 
patients, 5.5% (n=27) contracted SARS-
CoV-2 perioperatively, and in this group the 
30-day mortality rate was 14.8% (n=4).[11] At 
the Nuffield Orthopaedic Centre in the UK, 
9.4% of patients who underwent orthopaedic 
procedures as SARS-CoV-2-negative (n=9) 
contracted SARS-CoV-2 within 30 days 
postoperatively. [12] Of these patients, 66% 
(n=6) developed significant COVID-19-
related complications postoperatively, and 
there was a 33% (n=3) 30-day mortality rate. 
The overall 30-day mortality rate across the 
whole cohort of patients (n=96) during this 
period was 3% (n=3). Another UK-based 
study reported an overall survival rate of 
96% for patients undergoing emergency 
orthopaedic trauma surgery during the 
COVID-19 peak.[13] An Italian experience 
recorded an overall mortality of 4.6% (n=3) 
among fracture trauma patients.[14] Of those 
who died, 5.8% (n=1) were SARS-CoV-2-
positive and 4.1% (n=2) were SARS-CoV-
2-negative (p>0.05); 17 patients were SARS-
CoV-2-positive on admission or became 
positive within 14  days of admission. It is 
noteworthy that our perioperative SARS-
CoV-2 infection rate for patients we were 
able to obtain the data for was drastically 
lower than rates in these studies (Table 2).
Other international studies reported 
higher 30-day mortality and SARS-CoV-2 
infection rates than those reported by this 
study. These included the COVIDSurg 
international cohort study, which reported 
a 30-day postoperative mortality rate of 
28.8% (n=86/302) in patients undergoing 
orthopaedic procedures between 1 January 
and 31 March 2020.[5] All these patients 
had SARS-CoV-2 infection confirmed 
within 7 days before or 30 days after surgery. 
In this orthopaedic patient group, 44.3% 
(n=131) exhibited postoperative pulmonary 
complications, defined as pneumonia, acute 
respiratory distress syndrome or unexpected 
postoperative ventilation. A UK-based 
retrospective cohort study reported an 
increased postoperative mortality rate of 
30.5% (n=25/82) in COVID-19-positive 
patients undergoing hip fracture surgery, 
compared with a rate of 10.3% (n=35/340) 
in COVID-19-negative patients (p<0.001). [8] 
In another fracture study conducted in 
New York, 12.3% of the patient cohort 
(n=138) were COVID-19-positive and 10.1% 
suspec ted COVID-19-positive.[9] Increased 
mortality during hospitalisation and after 
30  days (53% of COVID-19-positive and 
14% of suspected COVID-19 patients) was 
reported when compared with COVID-19-
negative patients (Table 2).
Study limitations
This study has limitations. During the 
study period, the COVID-19 swabbing 
criteria continued to evolve, and the 
clinical diagnosis of suspected COVID-19 
patients was therefore not standardised. As 
previously mentioned, only COVID-19 PUI 
were swabbed for SARS-CoV-2 infection 
testing by quantitative PCR. We may have 
missed many negative COVID-19-screened, 
asymptomatic patients who were in fact 
positive for SARS-CoV-2 infection, yet this 
Patients undergoing orthopaedic 
surgical procedures,
N=346
Correct folder numbers captured
on REDCap database,
n=340
Incorrect folder numbers 








Fig. 2. Flow chart showing available data for our orthopaedic surgical cohort for the 30-day mortality 
assessment.
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would not have changed our primary outcome 
of overall mortality. It is important to note that 
asymptomatic carriers can transmit the virus 
during the incubation phase, posing a risk to 
patients in the ward, and to nursing and surgical 
staff.[4] Patient follow-up remains complex in the 
population serviced by our academic hospital. 
We were not able to successfully contact every 
patient who underwent surgery to assess their 
and their household contacts’ COVID-19 status 
postoperatively, which would have given our data 
more strength and improved accuracy of reporting. 
In addition, several patients were LTFU because 
they did not attend their follow-up appointments. 
In our case, LTFU does not mean ‘no death’. 
Although reporting of LTFU is quite rare in all the 
COVID survival-related studies to date, a study that 
excluded 21 patients and calculated the mortality 
percentage for the remaining patients reported a 
mortality rate of 5.4%,[15] while ours, for patients 
we were able to obtain 30-day mortality data for, 
was 2.5%. If we were to assume that all 35 patients 
for whom we are missing data died, our mortality 
rate would equate to 10%. This is still lower than 
the pooled prevalence mortality rate of 20% that 
took into account reports from UK, China, Turkey, 
India, Italy, Spain, the USA and France,[16] and 
an overall mortality rate of 15% reported by a 
Canadian study.[17] Our mortality rate, inclusive 
or exclusive of the missing data, falls within the 
globally reported rates. Further prospective studies 
with larger cohorts, comparing 30-day mortality 
data with previous years, and throughout the 
different COVID-19 peaks and in the presence of 
different SARS-CoV-2 variants, are needed for a 
deeper understanding of the risk associated with 
pre- and perioperative SARS-CoV-2 infection. 
In addition, we did not assess any postoperative 
complications in our SARS-CoV-2-positive patients.
Conclusions
We report a low 30-day mortality rate of 2.5% 
for patients undergoing orthopaedic surgery at 
our hospital during the first peak of the COVID-
19 pandemic in 2020 and a 30-day mortality 
rate of 0% for preoperatively confirmed SARS-
CoV-2-positive patients undergoing orthopaedic 
procedures. Of the 8 patients who died, 7 (87.5%) 
underwent surgery for orthopaedic trauma. We can 
conclude that it was safe to operate on orthopaedic 
patients at our academic hospital during the first 
COVID-19 peak in SA. COVID-19 status and 
30-day mortality data are important, as they will 
guide our surgeons on the most appropriate way to 
rapidly and safely resume elective and non-urgent 
surgery, with careful consideration of both patient 
and surgical staff risk.
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